Precision therapeutics: optimizing early discovery

Precision medicine tailors therapeutics to individual patients’ diseases, and is seen as the future of clinical practice. With significant time and financial investments being made in developing therapeutics, the ultimate success of patient-data driven precision therapies hinges on three main factors: the quality of the tissue samples, the associated molecular data, and the analysis used in their development.

Recently published in the European Biotechnology Magazine, the article with Jonathan Woodsmith, our VP Advanced Analytics & AI, covers Indivumed’s holistic approach and why high-quality tissue is foundational in precision medicine and drug development.